Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of drugs affecting the cardiovascular system.

Clinical chemistry and laboratory medicine - 1 Apr 2003

Siest Gérard, Ferrari Luc, Accaoui Marie-José, Batt Anne-Marie, Visvikis Sophie

Abstract excerpt

The variability in drug response originates partly from genetics, with possible consequences for drug efficacy, adverse effects, and toxicity. Until now, pharmacogenetics mainly indicated the best known source of variability, that is, the variability caused by drug metabolism. However, simultaneous progress in the knowledge of biochemical targets of drugs and of the human genome, together with the development of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Agents
Share to Cardiovascular System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Genotype

Share to Lipid Metabolism

Share to Mutation

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 12747607
DOI: 10.1515/CCLM.2003.089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of drugs affecting the cardiovascular system.PMID 12747607Read ↗

Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.Semantic proximity Read ↗

Use of pharmacogenomics in elderly patients treated for cardiovascular diseasesSemantic proximity Read ↗

Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.Semantic proximity Read ↗

Cardiovascular pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.Semantic proximity Read ↗

[Pharmacogenomics. What is relevant for the internal medicine specialist?].Semantic proximity Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.Semantic proximity Read ↗

Cardiovascular pharmacogenomics and individualized drug therapy.Semantic proximity Read ↗

Cardiovascular pharmacogenomics: current status and future directions.Semantic proximity Read ↗

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.Semantic proximity Read ↗

Expanding Role of Pharmacogenomics in the Management of Cardiovascular DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.